ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma

Author:

Arabzade Amir,Zhao Yanhua,Varadharajan SrinidhiORCID,Chen Hsiao-ChiORCID,Jessa SelinORCID,Rivas Bryan,Stuckert Austin J.ORCID,Solis Minerva,Kardian Alisha,Tlais DanaORCID,Golbourn Brian J.,Stanton Ann-Catherine J.,Chan Yuen San,Olson Calla,Karlin Kristen L.,Kong Kathleen,Kupp Robert,Hu BaoliORCID,Injac Sarah G.ORCID,Ngo MadelineORCID,Wang Peter R.,De León Luz A.,Sahm FelixORCID,Kawauchi DaisukeORCID,Pfister Stefan M.ORCID,Lin Charles Y.,Hodges H. CourtneyORCID,Singh Irtisha,Westbrook Thomas F.,Chintagumpala Murali M.,Blaney Susan M.,Parsons Donald W.,Pajtler Kristian W.,Agnihotri Sameer,Gilbertson Richard J.ORCID,Yi Joanna,Jabado Nada,Kleinman Claudia L.ORCID,Bertrand Kelsey C.,Deneen Benjamin,Mack Stephen C.ORCID

Funder

Cancer Prevention Research Institute of Texas

NIH-National Institute of Neurological Disease and Stroke

K12 award

Canadian Institutes of Health Research

NSERC

National Cancer Institute-Cancer Therapeutic Discovery

CPRIT

NCI

NIGMS

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3